Abstract: Disclosed are genetically modified nudiviruses capable of being sexually transmitted by an insect useful for controlling pest populations. The genetically modified nudiviruses are capable of causing sterility in a target population of insects. Also disclosed are insects infected with the disclosed genetically modified nudiviruses, methods of making the genetically modified nudiviruses, and methods of using the genetically modified nudiviruses to control an insect pest population.
Type:
Application
Filed:
May 13, 2016
Publication date:
November 17, 2016
Applicants:
Lepidext LLC, University of Kentucky Research Foundation
Inventors:
Bruce Webb, Kendra Hitz Steele, Angelika Fath-Goodin
Abstract: Compounds of formula (I) are useful for inhibiting a proteasome in a cell. Compounds, pharmaceutical compositions and methods of use are provided herein.
Type:
Grant
Filed:
April 7, 2015
Date of Patent:
November 15, 2016
Assignee:
University of Kentucky Research Foundation
Inventors:
Kyung-Bo Kim, Vinod Kasam, Wooin Lee, Dong-Eun Kim, Zach Miller, Chang-Guo Zhan, Do-Min Lee
Abstract: A method and system are provided for the production of triterpene including methylated triterpenes. The method and system include isolated nucleic acid sequences encoding triterpene methyltransferases such as triterpene methyltransferases 1, 2, 3. Advantageously, the method and system includes transgenic plant cells via an expression vector for triterpene methyltransferase and optionally various triterpene synthase and prenyltransferase all with tags directing these enzymes to the chloroplast of the transgenic plant cells for using the chloroplast methyl erythritol phosphate (MEP) pathway in the triterpene biogenesis.
Type:
Grant
Filed:
October 9, 2013
Date of Patent:
November 8, 2016
Assignee:
University of Kentucky Research Foundation
Inventors:
Joe Chappell, Thomas D. Niehaus, Shigeru Okada, Timothy P. Devarenne, David S. Watt
Abstract: The presently-disclosed subject matter includes methods and devices for diagnosing, prognosing, and treating brain damage in a subject, including brain damage caused by stroke or a traumatic brain injury (TBI). The methods can comprise providing a sample obtained from the subject, exposing the sample to an antibody selective for a visinin-like protein, detecting the presence of a complex that includes the antibody and the visinin-like protein, and diagnosing and/or prognosing the subject as having brain damage if there is the presence of the complex. Embodied methods can also comprise administering a treatment for brain damage if the subject includes the presence of the visinin-like protein.
Type:
Grant
Filed:
July 31, 2014
Date of Patent:
November 1, 2016
Assignee:
University of Kentucky Research Foundation
Inventors:
Mark A. Lovell, Bert C. Lynn, Melissa A. Bradley-Whitman
Abstract: A compact heat exchanger for veno-venous perfusion-induced hyperthermia includes an integral pneumatic pump and a hollow tubule heat exchange array. A veno-venous perfusion-induced hyperthermia system incorporating the compact heat exchanger is described. The heat exchanger provides a compact, efficient design allowing a lesser heat exchanging surface area and lesser required pumping power compared to conventional systems. In turn, the system provides a shorter blood circuit compared to conventional systems, allowing maintaining a lower blood temperature than such conventional systems while supplying sufficiently heated blood to patient visceral organs to provide a therapeutic effect, such as in supplementing chemotherapy drugs.
Type:
Grant
Filed:
August 13, 2012
Date of Patent:
October 18, 2016
Assignee:
THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
Inventors:
Dongfang Wang, Joseph B. Zwischenberger
Abstract: Novel devices and methods of capturing, controlling and preventing infestation of insects using microfabricated surfaces are provided. In particular, a mechanism of insect capture inspired by the microstructures of the leaf surfaces of plants and the key features of those surfaces with respect to the capture and control of pests have been determined and engineered into a variety of microfabricated surfaces capable of reproducing the effectiveness of these physical capture methods.
Type:
Grant
Filed:
February 26, 2013
Date of Patent:
October 18, 2016
Assignees:
The Regents of the University of California, The University of Kentucky Research Foundation
Inventors:
Catherine Loudon, Robert Corn, Megan Szyndler, Kenneth Haynes, Michael F. Potter
Abstract: A solvent for removal of an acid gas from a fluid stream includes a promoter amine with a pKa of between 6.5 and 10.5 and a tertiary amine with a pKa of between 8.5 and 10.5.
Type:
Grant
Filed:
March 29, 2013
Date of Patent:
October 18, 2016
Assignee:
THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
Inventors:
Joseph E. Remias, Cameron A. Lippert, Kunlei Liu
Abstract: The subject technology relates, in part, to a method of treating Alzheimer's Disease (AD), early-stage AD, elevated risk of AD, mild cognitive impairment (MCI), or other forms of age-related cognitive decline in a subject in need thereof by administering to the subject a molecule that promotes calcium-release stabilization in ryanodine receptors (RyRs) and/or inosital triphosphate receptors (InsP3Rs) in brain cells. Diagnostic methods using calcium-release stabilizing immunophilins, junctophilins or calmodulin are also disclosed.
Type:
Grant
Filed:
September 10, 2012
Date of Patent:
October 11, 2016
Assignee:
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
Inventors:
Philip W. Landfield, John Christopher Gant, Eric M. Blalock, Kuey-Chu Chen, Olivier Thibault, Nada Porter
Abstract: The presently-disclosed subject matter includes methods of identifying an Alu RNA inhibitor, and methods and compositions for inhibiting Alu RNA. Methods and compositions can be used for the treatment of geographic atrophy and other conditions of interest.
Type:
Grant
Filed:
July 3, 2014
Date of Patent:
October 11, 2016
Assignee:
University of Kentucky Research Foundation
Abstract: A method of protecting a cell includes inhibiting an inflammasome, MyD88, IL-18, VDAC1, VDAC2, caspase-8, and/or NF?B of the cell. Administering an inhibitor of MyD88, IL-18, VDAC1, VDAC2, caspase-8, and/or NF?B can protect the cell from Alu-RNA-induced degeneration. Protecting a cell, such as an retinal pigment epithelium (RPE), can be therapeutically useful in the context of age-related macular degeneration and geographic atrophy.
Type:
Grant
Filed:
January 17, 2014
Date of Patent:
September 27, 2016
Assignee:
University of Kentucky Research Foundation
Abstract: Mithramycin derivatives and their pharmaceutically acceptable salts are disclosed. The mithramycin derivatives can be used in the treatment of Ewing sarcoma or other cancer or neuro-disease associated with an aberrant erythroblast transformation-specific transcription factor.
Type:
Grant
Filed:
May 20, 2015
Date of Patent:
September 20, 2016
Assignee:
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
Inventors:
Jurgen T. Rohr, Daniel Scott, Markos Leggas, Jhong-Min Chen, Oleg V. Tsodikov
Abstract: The presently-disclosed subject matter includes compounds that comprise an initiator and an active agent that is covalently bonded to the initiator through a ring-opening polymerization process, an atom-transfer radical polymerization process, a Michael addition reaction, or a ring-opening metathesis polymerization process. In some embodiments the active agent includes simvastatin. The presently-disclosed subject matter also includes methods for making the compositions and methods for using the compositions to treat tissue wounds.
Type:
Grant
Filed:
October 2, 2014
Date of Patent:
September 6, 2016
Assignee:
University of Kentucky Research Foundation
Inventors:
David Puleo, Thomas Dziubla, Theodora Asafo-Adjei
Abstract: A method is provided for preparing a product from a precursor material. The method includes the steps of (a) mixing a particulate material and a binder to form a precursor material and (b) irradiating that precursor material with microwave radiation so as to activate the binder and form the product.
Type:
Grant
Filed:
March 7, 2014
Date of Patent:
August 30, 2016
Assignee:
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
Abstract: Butyrylcholinesterase (BChE) polypeptide variants of the presently-disclosed subject matter have enhanced catalytic efficiency for (?)-cocaine, as compared to wild-type BChE. Pharmaceutical compositions of the presently-disclosed subject matter include a BChE polypeptide variant having an enhanced catalytic efficiency for (?)-cocaine. A method of the presently-disclosed subject matter for treating a cocaine-induced condition includes administering to an individual an effective amount of a BChE polypeptide variant, as disclosed herein, to lower blood cocaine concentration.
Type:
Grant
Filed:
September 24, 2015
Date of Patent:
August 16, 2016
Assignee:
University of Kentucky Research Foundation
Inventors:
Chang-Guo Zhan, Fang Zheng, Wenchao Yang
Abstract: Glucan phosphatase nucleotide or polypeptide variants of the presently-disclosed subject matter can alter the biophysical properties of starch in vitro or in planta, as well as the total starch biomass production in planta as compared to plants expressing wild-type glucan phosphatases. Plants producing the polypeptide variants of the presently-disclosed subject matter can have increased starch accumulation, increased starched biomass, and/or starch having desired biophysical properties. A method of the presently-disclosed subject matter for producing altered starch includes providing a plant that produces a glucan phosphatase polypeptide variant that comprises an amino acid mutation and collecting starch from the plant.
Type:
Grant
Filed:
June 26, 2013
Date of Patent:
August 9, 2016
Assignee:
University of Kentucky Research Foundation
Abstract: A method of increasing the overall mass transfer rate of acid gas scrubbing solids is disclosed. Various catalyst compounds for that purpose are also disclosed.
Type:
Grant
Filed:
March 29, 2013
Date of Patent:
August 9, 2016
Assignee:
THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
Inventors:
Joseph E. Remias, Cameron A. Lippert, Kunlei Liu